Early Feasibility Study: Application of OCT Imaging in Dermatology

Status Completed

Clinical Trial Summary

Optical coherence tomography (OCT) is an established medical imaging technique that uses light to capture biological images from within optical scattering media (e.g., biological tissue). A high-resolution OCT has the characteristics of non-invasive, label-free, real-time, cellular resolution with high tissue penetration depth that are highly valuable for clinical use. AMO has developed an in-vivo OCT scanning system prototype based on the clinical needs and potential applications. This study is designed as an early feasibility study aiming for validation of AMO's in-vivo OCT scanning system in dermatology through collaboration with Mackay Memorial Hospital. The OCT can provide cellular-resolution (<1μm in lateral and axial directions) images which can be utilized to identify organelles. A high-resolution OCT has the characteristics of non-invasive, label-free, real-time, cellular resolution with high tissue penetration depth that are highly valuable for clinical use. The proposed scenario in this study is to collecting OCT images of skins with suspicious lesion including tumor, inflammatory diseases or pigment alteration as well as normal skin by using AMO's in vivo OCT imaging system. By using traditional pathological biopsy images or dermoscopic images as gold standard references, investigators will try to identify different characteristics in OCT images of skin with suspicious lesion including tumor, inflammatory diseases, or pigment alteration as well as normal skins.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Skin Diseases

Clinical Trial Details

NCT number	NCT04066582
Study type	Observational
Source	Mackay Memorial Hospital
Contact
Status	Completed
Phase
Start date	January 29, 2018
Completion date	October 2, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05038982` - Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin	Phase 2
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Recruiting	`NCT04818138` - BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort	N/A
Recruiting	`NCT05102396` - Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?	Phase 2
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT00772447` - China Registration Study in Patients With Skin Infections	Phase 3
Recruiting	`NCT01631617` - Effects of Treatments on Atopic Dermatitis	Phase 2
Active, not recruiting	`NCT04971200` - Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo	Early Phase 1
Completed	`NCT04144491` - Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda	N/A
Recruiting	`NCT04138342` - Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer	Phase 1
Recruiting	`NCT06061471` - To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis	Phase 2
Terminated	`NCT04775316` - Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
Recruiting	`NCT05765461` - Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe Xerosis
Withdrawn	`NCT04593914` - A Novel Skin Barrier Protectant for Acute Radiodermatitis	N/A
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Recruiting	`NCT06092866` - Digital Versus Telephone Symptom Assessment and Triage in Primary Care	N/A
Recruiting	`NCT04901325` - Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)	Phase 2
Recruiting	`NCT01917279` - Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC	Phase 3
Completed	`NCT01975038` - Adaption of the Skin Sun Sensitivity Scale	N/A
Recruiting	`NCT01427400` - The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction	Phase 4